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Mycobacterium tuberculosis is the second leading cause of death from infectious agent. This study sought to 
detect M. tuberculosis genes, which were specifically expressed, or upregulated during intracellular infection of 
J774 murine macrophages; as such genes may be potential targets for novel drug action. J774 murine macrophage 
cell line was infected with M. tuberculosis (H37Rv strain) at 10:1 multiplicity of infection (MOI). RNA was 
differentially extracted from M. tuberculosis infecting J774 macrophage cell line. The control in this case was RNA 
from extracellular broth grown bacteria. Approximately 50 ng of RNA from intracellular derived bacteria and 
extracellular derived bacteria (control) were subjected to random arbitrarily primed PCR (RAP-PCR) using 50 
primer combinations. Eleven differential RAP-PCR products were observed. All RAP-PCR products were cloned 
into pCR®2.1 and sequenced in order to determine the identity of the products. Four of the eleven products were 
derived from macrophage genes and another 4 products were derived from the M. tuberculosis rRNA genes (three 
23S and one 16S rRNA). The 3 remaining RAP-PCR products were found to be mycobacterial genes other than 
ribosomal genes. The three products were genes encoding enzyme involving in a shikimate pathway, a putative 
carboxyphosphonoenolpyruvate phosphonomutase and a serine protease with homology to HtrA. Of the 3 
mycobacterial genes other than ribosomal genes detected, none were specifically expressed during intracellular 
infection but competitive RT-PCR showed that aroF gene was upregulated two-fold in intracellular derived 
bacilli. 
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INTRODUCTION 
Mycobacterium tuberculosis is the second leading cause 
of death from any infectious agents in developed and 
developing countries after deaths due to human 
immunodeficiency virus (HIV), accounting for one-
third of the mortality due to infectious. Over the past 
few years, there has been an increased in the 
incidence of tuberculosis partly due to the HIV 
infection pandemic [1]. About 9.2 million people was 
estimated to be new cases of tuberculosis (TB) 
worldwide in 2006 – an increase of 0.6 % from 2005 
with 1.7 million died from the disease [2]. The 
emergence of multi-drug resistant strains of M. 
tuberculosis [3] also complicated the treatment of this 
infection. In addition, there is no adequate vaccine for 
prevention of the disease. The BCG vaccine - a 
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vaccine of choice in most of the countries has variable 
degree of vaccine efficacy ranging from 0 to 90% [4-6]. 
Therefore, there is need for new intervention in terms 
of new chemotherapeutic agents and design of 
effective vaccines. Design of new chemotherapeutic 
agents and vaccines require better understanding of 
the basic biology of the organism including the 
metabolism.  How M. tuberculosis survives the early 
interaction with the alveolar macrophages still 
remains a mystery. Understanding the survival 
mechanisms of M. tuberculosis could only come from 
the use of molecular biological techniques. Many of 
the molecular biological techniques require the use of 
a well-developed genetic system for mycobacteria. 
Progresses have been made in this area over the last 
few years with the development of transposon 
mutagenesis [7], homologous recombination [8], and 
in vivo complementation test [9, 10]. The difficulty in 
applying some of these techniques called for the use 
of other techniques that do not rely on a well-
developed genetic system such as RNA based 
approach. The expression of a gene is indicated by the 
transcription of a particular segment of DNA into 
RNA representing the template carrying the 
necessary information for protein synthesis. RNA 
synthesis is in a continuous state of flux, which could 
be a reflection of environmental changes or demand 
for a particular gene to carry out a specific function. 
Plum and Clark-Curtiss (1994) had used RNA-cDNA 
subtractive hybridisation to identify a macrophage 
induced gene that was expressed by M. avium during 
tissue culture infection [11]. Another approach using 
the RNA based approach is arbitrary-primed 
polymerase chain reaction (AP-PCR) or differential 
display reverse transcription PCR (DDRT-PCR). AP-
PCR or DDRT-PCR developed by Liang and Pardee 
(1992) is based on the use of random primers to 
identify differences in gene expression between two 
target cell populations [12]. Wong and McClelland 
(1994) used this approach to study differential gene 
expression when S. typhimurium was exposed to 
oxidative stress (H2O2) [13]. Kwaik and Pederson 
(1996) had used a similar technique to identify a gene 
specifically expressed (eml – early stage macrophage-
induced locus) by Legionella pneumophila during 
macrophage residency [14]. RNA extraction 
techniques have improved in mycobacteria over the 
last few years [15, 16], which makes it feasible for 
anybody who wants to study gene expression via 
transcription This study was aimed at using RAP-
PCR to detect genes that are differentially expressed 
by M. tuberculosis during the intracellular infection of 
macrophages.  
 
MATERIALS AND METHODS 
 
Maintenance and culture of mycobacteria.  
Mycobacteria species used in this study was M. 
tuberculosis H37Rv (ATCC 9360) obtained from the 
National Culture Type Collection, Colindale, UK. 
Mycobacteria were grown to mid log phase in 
Middlebrook 7H9 broth (Difco Laboratories Ltd., 
Surrey, UK) supplemented with 10% albumin-
dextrose catalase enrichment (ADC; Difco) and 0.02% 
Tween 80 (Sigma, Dorset, UK) at 37oC (in the presence 
of 5% CO2 for M. tuberculosis) before harvesting at 0.5-
1.0 OD600. M. tuberculosis H37Rv cultures were also 
grown for 3 weeks at 37oC on thick 7H10 agar plates 
supplemented with 10% oleic acid-albumin-dextrose 
catalase enrichment (OADC; Difco) and 0.2% glycerol 
and then stored at 4oC. 
Maintenance and culture of macrophage cell line. 
The murine macrophage cell line J774.2 (obtained 
from European Collection of Cell Cultures, CAMR, 
Porton Down, Salisbury, UK) was used in all infection 
experiments. J774.2 macrophages were cultured in 
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Dulbecco’s modified Eagle’s medium (DMEM) 
containing 5% heat-inactivated foetal bovine serum 
(Life Technologies, Paisley, UK) with no antibiotic 
supplements. Macrophage monolayers were 
maintained at 37oC in humidified air containing 5% 
CO2 before and after infection. For storage purposes, 
cell pellets were suspended in 9% dimethyl 
sulphoxide (DMSO) in foetal bovine serum (FBS) at a 
concentration of approximately 4 × 106 cells/ml and 
aliquoted into 1 ml cryo-vials (Nunc, UK). The vials 
were placed in a polysytrene box and then placed at -
20oC overnight before transferring to liquid nitrogen. 
 
Macrophage infections and preparation of RNA.  
J774.2 macrophages were synchronously infected 
overnight with non-opsonised static cultured of 10:1 
M. tuberculosis bacilli in mid log phase [17]. After 4 hr 
the medium was discarded and washed in three 
changes of Hanks’ balanced salt solution (HBSS) to 
remove the extracellular bacilli before the infected cell 
line layer was resuspended in DMEM. A control 
comprised M. tuberculosis bacilli growing in 
Middlebrook 7H9/ADC/Tween 80 broth without 
shaking. RNA was prepared from macrophages 
infected with M. tuberculosis using a method based on 
a differential lysis after overnight incubation. Briefly, 
the culture medium was discarded and the infected 
macrophage monolayer was re-suspended in 25 ml 
guanidine thiocyanate (GTC) solution per flask to lyse 
the macrophages. In order to reduce the viscosity of 
the solution, a long thin nosed plastic Pasteur pipette 
was used to squirt the lysate solution in and out with 
force to shear the macrophage nucleic acids. The 
lysates were transferred to 30 ml sterile universal 
tubes and centrifuged at 2,500×g for 20 min to 
concentrate the intracellular bacilli. The pellets of 
intracellular bacilli were combined using 1 ml of wash 
solution (1 ml 0.5 % Tween 80) and transferred to a 
1.5 ml Eppendorf tube and centrifuged in a 
microcentrifuge at 12,000×g for 30 sec. The 
supernatant (wash solution) was saved and placed in 
a fresh Eppendorf tube and stored at -80oC. The pellet 
of bacteria was re-suspended in 200 µl of sterile DEPC 
treated water. The RNA was extracted from the 
harvested intracellular bacilli and the extracellular 
bacilli control using Mangan et al’s method [16]. All 
RNA samples were DNase I (Pharmacia, UK) treated 
to destroy any contaminating DNA by incubating the 




Two different concentrations of the RNA 
(approximately 50 ηg and 25 ηg) extracted from the 
intracellular bacilli and the controls (extracellular 
bacilli control and the saved Tween 80 wash from the 
intracellular bacilli) were reverse transcribed in a 20 
µl reaction volume containing 0.5 µM of arbitrary 
primer (15-20-mer) with 0.5 mM each of dATP, dGTP, 
dCTP and dTTP with 100 U SuperscriptTM II RNase H- 
reverse transcriptase (Invitrogen) in the presence of 50 
mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2 and 
10 mM dithiothreitol (DTT) following the 
manufacturer’s instructions. Briefly, the RNA sample 
and the arbitrary primer were incubated together for 
15 min at 70oC and chilled on ice before the addition 
of dNTPs. This was incubated for 2 min at 42oC. 
Thereafter, reverse transcriptase was added. The 
reaction mixes were first incubated at 25oC for 15 min 
to allow for non-specific hybridization and finally 
incubated for 50 min at 42oC to allow for cDNA 
synthesis. Following cDNA synthesis, the reverse 
transcriptase was denatured for 15 min at 70oC. One 
tenth of the cDNA representing 2 µl was amplified in 
a 20 µl PCR reaction volume containing 0.5 µM of 
arbitrary primer (15 – 20 mer), 10 mM Tris-HCl (pH 
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8.3), 1.5 mM MgCl2, 50 mm KCl, 0.01% gelatin, and 
62.5 µM of dNTPs, and 1 U of Taq polymerase.  The 
PCR parameters used were denaturation (94oC, 30 
sec), annealing (35oC, 1 min), and extension (72oC, 2 
min) for 45 cycles in a Perkin-Elmer Gene Amp 9600 
thermal cycler. With RAP PCR strategy, 50 primer 
combinations were used. Following RAP-PCR, 7 µl 
portions of the RAP-PCR products were added to 2 µl 
of sample loading buffer and the samples were 
electrophoresed along with a 100 bp DNA ladder 
marker through a Clean gel using the Multiphor 
system. Following electrophoresis, the gel was silver 
stained. Differential RAP-PCR products were excised 
from the gel. The excised DNA bands were eluted 
and re-amplified as before. The reproducibility of the 
RAP product was re-assessed using the same cDNA, 
new cDNA preparation from the same RNA samples 
and also cDNA from independent infection 
experiment prior to cloning and sequencing. 
 
Cloning and Sequencing.  
RAP products were re-amplified using the same 
cycling parameters which generated the original 
product except that the final extension step at 72oC 
was increased to 10 min to provide TA overhangs. 
The re-amplified RAP product was cloned using TA 
cloning kit (Invitrogen, The Netherlands.) into a 
plasmid cloning vector (pCR2.1) following 
manufacturer’s instructions. Plasmid DNA was 
extracted using the method of Birnboim and Doly 
[18]. PCR was used to screen the plasmid for the 
cloned RAP product and the plasmid containing the 
desired RAP product was used in sequencing. 
Sequencing was undertaken using the ABI PRISMTM 
dye terminator cycle sequencing kit (Applied 
Biosystems) following manufacturer’s conditions. The 
sequencing products were sent to Alta Bioscience, 
University of Birmingham, Birmingham, UK for 
analysis. 
 
Computer analysis of sequence data.  
Nucleotide sequences  were analysed using the 
University of Wincosin’s Genetics Computer Group 
(GCG) software package [19] on the UNIX system of 
the University of Birmingham Bioinformatics Unit. 
The BLAST programs [20]  were carried out at the 
National Institute for Biotechnology Information, 
National Institute of Health, The Institute of Genetic 
Research, USA and Sanger Centre,  Cambridge, UK. 
 
Quantitative Competitive RT-PCR.  
RNA (0.5 µg) was reverse transcribed in a 20 µl 
containing 0.5 µM of downstream primer AROFB (5’-
GGATCACATGCCGTCTCATA-3’) for aroF gene , 50 
mM Tris-HCl pH 8.3; 75 mM KCl; 3 mM MgCl2 and 
10 mM DTT with 10 units of Superscript RNase H- 
reverse transcriptase. The reaction was incubated at 
42oC for 50 min. The reaction was stopped by 
incubating at 70oC for 15 min. Quantitative RT-PCR 
was performed using the method described by Celi et 
al [21] in preparing the competitive template. In this 
assay, the concentration of the cDNA was adjusted 
based on 16s cDNA relative concentration and fixed 
in a competitive PCR containing series of two fold 
dilution of the competitive template for aroF, 15% 
glycerol, 0.125 mM of dNTP, 10 mM Tris-HCl, pH 8.3, 
1.5 mM MgCl2, 50 mM KCl, 0.01% gelatin, 1 µM 
AROFA (5’-GTCACTTCGATCGCATTGTC-3’) and 1 
µM AROFB (5’-GGATCACATGCCGTCTCATA-3’). 
The cycling parameters used are as following: 94oC - 5 
min for 1 cycle; 94oC - 30 s; 50oC - 30 s; 72oC - 30 s for 
35 cycles and 72oC - 10 min. for 1 cycle. The expected 
product sizes for the competitive and cDNA 





The RNA extracted from the bacterial pellets 
represented majority of the intracellular M. 
tuberculosis following selective removal of 
macrophage nucleic acids as indicated by the 
presence of 16S and 23S bands on agarose gel (data 
not shown). Using RAP-PCR, eleven products were 
identified of which three RAP products were 
identified from M. tuberculosis (H37Rv) during 
intracellular infection that appeared not to be present 
in the extracellular bacilli (mycobacteria grown in 
Middlebrook's medium) using 50 primers 
combination. Four out of the eleven were macrophage 
genes with another 4 RAP products being 
mycobacterial ribosomal RNA genes (three 23s rRNA 
and one 16s rRNA genes). The three remaining RAP 
products were found to be mycobacterial genes apart 
from the ribosomal genes earlier mentioned. The 
three RAP Products were designated RAP 61, RAP 
136 and RAP 148. The first RAP product - RAP61-1 
(figure 1) was found to be about 400 bp. Two hundred 
and seventy bases were sequenced and subjected to 
computer analysis. The DNA search on NCBI using 
the BLAST programme showed that the DNA has 
homology to a gene on M. leprae cosmid B1559 
(p=9.2e-63) and also to SEC101 gene of Streptomycess 
lividans (p=2.1e-36). At amino acid level using the 
BLASTX programme, the gene was found to show 
strong homology to other aroF from plants and other 
bacteria. Apart from this particular gene, it also 
showed homology to phenazine F of Pseudomonas 
aureofaciens (p=7.0e-06). The gene annotation in Sanger 
centre database showed the gene coded for a product 
with 462 amino acid residues with strong homology 
to aroF gene of plants. The aroF gene has 48% identity 
over 444 amino acid residues with the aroF of 
Helicobacter pylori, 90% identity to aroF of M. leprae 
over 462 amino acid residues, 50% identity to 
Arabidopsis thaliana over 436 amino acid residues and 
43% identity to phenazine F of Pseudomonas 
aureofaciens over 429 amino acid residues. The 
sequence alignment of the putative AroF in figure 2 
shows how related the AroF of M. tuberculosis to AroF 
of plants and bacteria.  
 
The second differential RAP product - RAP 136-
9 (data not shown) was found to be about 300 bp 
in size. Sequencing result showed that this gene 
has homology with a gene on MTCY39 (p=0.0) 
using the FASTA program on GCG at DNA 
level. The function of the gene is not known but 
it has homology with 
carboxyphosphonoenolpyruvate 
phosphonomutase gene of Streptomyces 
hygroscopicus (p=0.17) and unknown protein of 
Saccharopolyspora erythraea (p=1.9e-56) at amino 
acid level using BLASTP progamme at NCBI. 
This unknown protein of Saccharopolyspora 
erythraea has been implicated in the final 
hydroxylation step in erythromycin biosynthesis 
[22]. Carboxyphosphoenolpyruvate 
Figure 1. An autoradiograph of the 33P labeled 
RAP-PCR products derived from cDNA of 
intra- Cellular  M. tuberculosis after 15 hr of 
infection of J774.2  macrophage like cells (lane 
1), in-vitro grown M. tuberculosis (lane 2) and 
from J774.2 macrophage (lane 3). The 
arrowhead shows the RAP-61 whose RAP-PCR  




phosphonomutase has been characterised 
hygroscopicus SF1293 [23]. The general clue that 
we could derived from the result of the database 
search is that this gene might be involved in 
antibiotic synthesisas an enzyme catalyzing the 
formation of an unusual C-P bond that is 
involved in the biosynthesis of the antibiotic 
bialaphos (BA) in Streptomyces.  
The third differential RAP-145 (data not shown) 
obtained using this approach with new primers  
set gave about 200 bp in size. The sequencing 
result showed that this product was found to 
have 100% homology to a cosmid MTCY16A12 
on searching the M. tuberculosis DNA database 
at Sanger centre. The whole sequence (about 
6,400 bp) of the cosmid was pulled out for 
further analysis at BCM using the program 
called BCM gene finder. Using this program the 
RAP 145 was within one of the two potential  
genes on the cosmid. The putative translated 
sequence of the gene which was 464 amino acids 
was subjected to further computer analysis to 
find the likely identity of the gene on the gene 
database at NCBI. This gene was found to show 
homology to most of the high temperature 
response (htrA) genes from other bacteria 








The degree of homology to the htrA gene of the 
M. tuberculosis was not 100% suggesting that this 
gene is not htrA but has similar properties to the 
htrA gene. At the upstream of the htrA-like gene 
was the two component regulatory gene with 
homology to other two component regulatory  
genes in the GENBANK database. The htrA-like 
gene on Sanger’s database is referred to as serine 
protease gene. Further computer analysis 
revealed that this protein is a membrane bound 
protein as indicated by the presence of the 
myristotyl domain. 
To confirm that genes detected by RAP-PCR 
were differentially expressed a PCR based 
strategy had to be developed because of the 
small amount of RNA obtained from 
intracellular bacilli (typically, 20 ng from a flask 
of infected macrophages) negating the 
possibility of using Northern analysis or RNAse 
protection assays to confirm upregulation of 
gene expression. It was essential that for any 
comparative gene expression study that the 




Figure 2. Alignment of the deduced amino acid sequence 
of the M. tuberculosis DAHP synthase with homologs from 
Pseudomonas auereofaciens  M. leprae (AL022602), M. 
tuberculosis (AL021957), Arabidopsis .thaliana (M74819), 
Solanum .tuberosum (P37822), H.pylori (024947) and P. 
auereofaciens (L488339). The positions and identities of 
amino acids common to all the six proteins are in bold 
letters. The sequences for all DAHP synthase were 
obtained from GenBank at NCBI. For protein alignments, 
we used programs within the Genetics Computer Group 
sequencing Analysis Saftware package (GCG, Madison, 
USA). 
101                                                  150
M.leprae MRTVLESVPP VTVPSEIIRL QEQLALVANG KAFLLQGGDC AETFVDNTEP
M.tuberculosis MRTVLESVPP VTVPSEIVRL QEQLAQVAKG EAFLLQGGDC AETFMDNTEP
A.thaliana VLKTIEAFPP IVFAGEARNL EERLADAAVG KAFLLQGGDC AESFKEFNAT
S.tuberosum VLKTLEMNPP LVFAGEARSL EEKLGEAALG KAFLLQGGDC AESFKEFNAN
H.pylori VKKELHSYPP LVFAGEARNL QERLAQVIDN KAFLLQGGDC AESFSQFSAN
P.auereofaciens AQAYLRDSAS LIRVEDILVL RATLARVAAG EAMVIQSGDC AEDMDESTPD
Consensus  ----L---PP L----E---L QE-LA--A-G -AFLLQGGDC AE-F-E----
151                                            200
M.leprae HIRSNVRTLL QMAVVLTYGA SLPVVKVARI AGQYAKPRS. ..ADVDALGL
M.tuberculosis HIRGNVRALL QMAVVLTYGA SMPVVKVARI AGQYAKPRS. ..ADIDALGL
A.thaliana NIRDTFRVLL QMSIVLTFGG QVPVIKVGRM AGQFAKPRSD AFEEKDGVKL
S.tuberosum NIRDTFRILL QMSVVLMFGG QVPVIKVGRM AGQFAKPRSD PLEEINGVKL
H.pylori RIRDMFKVMM QMAIVLTFAG SIPIVKVGRI AGQFAKPRSN ATEMLDNEEV
P.auereofaciens HVARKAAVLD ILAGTFRLVT QQPVVRVGRI AGQFAKPRSN NNERIGDVEL
Consensus  -IR---R-LL QM-VVL-F-- --PVVKV-R- AGQFAKPRS- ----I----L
201                                            250
M.leprae KSYRGDMING FAPDAAAREH DPSRLVRAYA NSSAAMNLVR ALTSSGLASL
M.tuberculosis RSYRGDMING FAPDAAAREH DPSRLVRAYA NASAAMNLVR ALTSSGLASL
A.thaliana PSYKGDNING DTFDEKSRIP DPNRMIRAYT QSAATLNLLR AFATGGYAAI
S.tuberosum PSYKGDNING DTFDEKSRIP DPHRLIRAYM QSAATLNLLR AFATGGYAAM
H.pylori LSYRGDIING ..ISKKEREP NPERMLKAYH QSVATLNLIR AFAQGGLADL
P.auereofaciens PVYRGDMVNG REAVCGHRQH DAQRLVRGY. .......... ..........
Consensus  -SYRGD-ING -------R-- DP-RLVRAY- ---A-LNL-R A----G-A-L
251                                            300
M.leprae HLVHDWNREF VRTSPAGARY EALAGEIGRG LAFMSACGVA DRN...LQTA
M.tuberculosis HLVHDWNREF VRTSPAGARY EALATEIDRG LRFMSACGVA DRN...LQTA
A.thaliana QRVTQWNLDF VEQSEQADRY QELANRVDEA LGFMSACGLG TDH.PLMTTT
S.tuberosum QRVTEWNLDF VENCEQGDRY QELAHRVDEA LGFMAAAGLT VDH.PIMSTT
H.pylori EQVHRFNLDF VKNNDFGQKY QQIADRITQA LGFMRACGVE IERTPILREV
P.auereofaciens..  ........ .......... .SAARDIMQH LGWKASAS.. ...QEQLSGS
Consensus  --V---N-DF V-------RY Q-LA--I--- L-FM-A-G-- ------L---
301                                            350
M.leprae EIYASHEALV LDYERAMLRL AGAPEGPDDG LQLYDLSAHT VWIGERTRQL
M.tuberculosis EIYASHEALV LDYERAMLRL S...DGDDGE PQLFDLSAHT VWIGERTRQI
A.thaliana DFYTSHECLL LPYEQSLTRL DSTSG..... .LYYDCSAHM VWCGERTRQL
S.tuberosum DFWTSHECLL LPYEQALTRE DSTSG..... .LFYDCSAHM VWVGERTRQL
H.pylori EFYTSHEALL LHYEEPLVRK DSLTN..... .QFYDCSAHM LWIGERTRDP
P.auereofaciens PAWTNHEMLV LDYELPQLRQ D.......EQ GRVFLGSTHW PWIGERTRQL
Consensus  E-Y-SHE-L- L-YE--L-R- ---------- ---YD-SAH- -WIGERTRQL
351                                            400
M.leprae DGAHVAFAEV IANPIGVKMG ATMTPELAVE YVERLDPHNK PGRLTLVSRL
M.tuberculosis DGAHIAFAQV IANPVGVKLG PNMTPELAVE YVERLDPHNK PGRLTLVSRM
A.thaliana DGAHVEFLRG IANPLGIKVS NKMDPFELVK LVEILNPNNK PGRITVIVRM
S.tuberosum DGAHVEFLRG VANPLGIKVS QKMDPNELIK LIDILNPANK PGRITVIVRM
H.pylori KGAHVEFLRG VCNPIGVKIG PNASVSEVLE LCDVLNPRNI KGRLNLIVRM
P.auereofaciens TGAHVTLLSE VLNPVACKVG PDITQDQLLS LCERLDAKRE PGRLTLIARM
Consensus  -GAHV-F--- --NP-GVKV- --------V- --E-L-P-N- PGRLT-I-RM
401                                            450
M.leprae GNNKVRDVLP PIVEKVKATG HQVIWQCDPM HGNTHESSTG YKTRHFDRVV
M.tuberculosis GNHKVRDLLP PIVEKVQATG HQVIWQCDPM HGNTHESSTG FKTRHFDRIV
A.thaliana GAENMRVKLP HLIRAVRRSG QIVTWVCDPM HGNTIKSTCG LKTRAFDSIL
S.tuberosum GAENMRVKLS HLVRAVRGAG QIVTWVCDPM HGNTIKAPCG LKTRAFDSIL
H.pylori GSKMIKERLP KLLQGVLEEK RHILWSIDPM HGNTVKTSLG VKTRAFDSVL
P.auereofaciens GAQKVAERLP PLVEAVRQAG HKIIWLSDPM HGNTIVAPCG NKTRMVQAIT
Consensus  G----R--LP -LV--V---G --V-W--DPM HGNT-----G -KTR-FD-I-
451                                            500
M.leprae DEVQGFFEVH RALGTYPGGI HVEITGEDVT ECLGGAQDIS DTDLAGRYET
M.tuberculosis DEVQGFFEVH RALGTHPGGI HVEITGENVT ECLGGAQDIS ETDLAGRYET
A.thaliana AEVRAFLDVH EQEGSHAGGI HLEMTGQNVT ECIGGSRTVT YDDLSSRYHT
S.tuberosum AEVRAFFDVH EQEGSHPGGI HLEMTGQNVT ECIGGSRTVT YDDLGSRYHT
H.pylori DEVKSFFEIH RAEGSLASGV HLEMTGENVT ECIGGSQAIT EEGLSCHYYT
P.auereofaciens EEIAAFKHAV TSAGGVAAGL HLETTPDDVS ECASDAAGLH Q..VASRYKS
Consensus  -EV--F-EVH ---G----GI H-E-TGE-VT ECIGG---I- ---L--RY-T
501
M.leprae ACDPRLNTQQ SLELAFLVAE MLRD~~~~~~ ~~~
M.tuberculosis ACDPRLNTQQ SLELAFLVAE MLRD~~~~~~ ~~~
A.thaliana HCDPRLNASQ SLELAFIVAE RLRKRRTGSQ RVS
S.tuberosum HCDPRLNASQ SLELSFIVAE RLRRRRMSTQ RL~
H.pylori QCDPRLNATQ ALELAFLIAD MLKKQHA~~~ ~~~
P.auereofaciens LCDPRLNPWQ AITAVMAWKN QPSSTLASF~ ~~~





                  
 
                                                                                        




                     





                                                                                          Figure 4. Competitive PCR for cDNA of aroF gene in intracellular                       
                                                                                          bacilli and broth cultures of M. tuberculosis.Various amounts of aroF 
  Figure 3 Competitive PCR for 16s cDNA                  competitive DNA (2-fold dilutions of the competitive template)  
  to confirm equal proportion of cDNA used                     competed against a fixed concentration of aroF cDNA from intracellular 
  in the competitive PCR for aroF gene                        bacilli and broth cultured M. tuberculosis.Lanes 1 - 4:  Intracellular 
  homolog competed in  figure 4.                                          bacilli (in duplicate); lanes 5 - 8: broth cultured bacilli (in duplicate);                                       
                                                                                          lanes 9 & 10: PCR negative and  positive controls,  respectively and 
                                                                             lane 11: 100 bp DNA ladder marker. 
 
 
Determining the concentration of RNA in the 
test sample was particularly problematic owing 
to the contribution of the macrophage RNA 
despite the removal of host nucleic acids during 
selective lysis of the macrophages. Competitive 
RT-PCR was employed in order to rule out some 
background inherited using RNA dot blot 
hybridisation and the insensitive of the 
technique to detect small variation in the 
samples. Using this approach, putative pepp 
gene was found not to be upregulated using 
limiting dilution PCR and htrA-like gene was 
found also not to be upregulated after 15 hr of 
intracellular infection by quantitative 
competitive PCR (data not shown). There was at 
least 2 fold (2.3 ± 0.8) in the level of expression 
of aroF gene in M. tuberculosis as shown in figure 
3 during intracellular infection of macrophages 








Our strategy in using synchronised method of 
infecting the macrophages was to force all the 
mycobacteria into the same stage in the 
infectious cycle with the harvesting of the RNA 
representing 15 hr of infection. The infection 
process was to favour the uptake of the bacilli 
by the macrophages in order to be able to detect 
the genes that are expressed in order to survive 
inside the macrophage on a long term basis i.e. 
the genes that are very important for the 
parasitic existence of the bacilli inside the 
macrophages which might include the metabolic 
genes. Differential lysis of the macrophages and 
M. tuberculosis (H37Rv) was adopted with the 











































                 Figure 5: The pre-chorismate pathway of bacteria. 
 
This method developed by Philip Butcher's 
group [16] exploited the differences in the cell 
architecture of the host and mycobacterium. The 
tender nature of the macrophage cell membrane 
makes it more susceptible to lysis than 
mycobacteria. This process of lysis has also 
taken into consideration of preserving the 
mycobacterial RNA with guanidine thiocyanate 
solution. Macrophage induced gene homologue  
has been found to be upregulated in M. 
tuberculosis based on the  RNA extraction 
method [24]. With this strategy, the quantity of 
the RNA from mycobacteria within the 
intracellular environment could be roughly 
assessed for RAP experiment without a wide 
departure from the actual concentration. All 
together, three RAP products of interest were 
identified after eliminating the host genes and 
ribosomal genes for mycobacteria using 50 
primer combinations. The low detection of 
differentially expressed gene might be as a 
result of using conventional PCR in amplifying 
cDNA which does not favour the amplification 
of DNA fragment with high G:C content. We are 
currently addressing this issue.  
 
The htrA-like (serine protease) gene identified in 
this study was found not to be differentially 
expressed suggestive that this gene play little 
role in the intracellular survival of M. 
tuberculosis. This does not come as a surprise 
because of the presence of more than one related 
genes which could complement each other in 
functions. HtrA mutants of bacteria namely 
Brucella abortus, Yersinia enterocolitica showed 
decrease  resistance to killing within 
macrophages [25, 26],  but it is most likely that 
htrA mutant of M. tuberculosis will not behave in 
a similar way as with the other bacteria. Further 




the neighboring gene (putative two component 
regulatory gene) will throw some light on the 
pattern of expression and whether two-
component regulatory gene does have some 
roles to play in controlling the expression of 
htrA-like gene in the early stage of infection. In 
addition to the genes identified in this study, we 
found upregulation of the aroF gene during 
intracellular infection of macrophages. The 
product of this gene is 3-deoxy-D-arabino-
heptulosonic acid 7 -phosphate synthase 
(DAHP) which is the first enzyme in the 
shikimate pathwa with the final product of this 
pathway being chorismate - a precursor of many 
aromatic compounds (figure 5). The 
upregulation of aroF coding for this protein 
shows the importance of this particular pathway 
to the intracellular survival of M. tuberculosis. 
We could speculates that the increased in 
metabolic demand for the final product of this 
pathway in the synthesis of 2, 3-
dihydroxybenzoic acid (a component of certain 
siderophores, which participate in the entry of 
iron into the cell) and p-hydrobenzoic acid ( a 
precursor of the quinones) could lead to 
upregulation of aroF gene. For effective bacterial 
pathogenesis, the organism must sense its 
environment appropriately and respond with 
coordinate alterations in the expression of 
virulence genes. A number of environmental 
factors, including pH, osmolarity, temperature, 
and amino acid concentration, co-ordinately 
regulate the expression of virulence genes [27]. 
Since free iron is extremely limited in the 
mammalian host, a shift from a high to a low-
iron environment is an important environmental 
signal to bacteria for coordinate regulation of 
gene expression. And to acquire this bound iron, 
bacteria have evolved a system for acquiring 
this element, in case of mycobacteria - a 
mycobactin and the precursors for the synthesis 
of this compound is the chorismate. We further 
speculate that in order to carry out this function 
i.e. iron acquisition from transferrin, it makes 
sense that the pathway leading to the synthesis 
of this compound is upregulated. Another 
condition that could lead to the upregulation of 
this gene is the differences in the oxygen tension 
between intracellular environment of the 
macrophage and broth culture environment. 
Although standing culture was used as the 
control but there would still be a subtle 
difference in the oxygen tension. In order to 
maximise the survival chance of M. tuberculosis, 
the menaquinone synthesis has to be increased 
of which the precursor is chorismate and this 
could directly or indirectly control the 
expression of aroF gene. Arabidopsis thaliana aroF 
gene has been shown to be upregulated in 
response to pathogenic attack to Pseudomonas 
syringae [28] which is as a result of the induction 
of phenylalanine ammonia lyase - the first 
enzyme in phenylpropanoid pathway and other 
enzymes specific to lignin synthesis and 
secondary metabolism in order to provide 
aromatic precursors for the synthesis of 
defensive secondary metabolites to contain 
bacterial proliferation. Analogy of this 
phenomenon could happen in M. tuberculosis in 
order to produce precursors for the synthesis of 
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defensive secondary metabolites which could be 
antibiotic in nature. The aroF gene was also 
found to be upregulated in Escherichia coli grown 
in glucose, acetate, and glycerol media [29]. 
Chorismate/shikimate pathway is very 
important for bacteria survival, this probably 
explain why most preventable or curative 
approaches have been geared towards this 
pathway. The shikimate pathway in M. 
tuberculosis has long attracted attention as the 
potential target of finding a new vaccine or 
chemotherapeutic agent [30, 31]. In micro-
organisms and plants, chorismic acid is a central 
precursor for the biosynthesis of an array of 
biochemically important and structurally 
diverse aromatic compounds. These include 
folic acid, vitamin K, ubiquinone and the three 
aromatic acids - phenylalanine, tyrosine and 
tryptophan [32]. The enzymes of the aromatic 
biosynthetic pathway are attractive targets for 
inhibitors since this pathway is absent in 
mammals. 6-Fluoroshikimic acid has been 
shown to be converted in vivo by the pre-
chorismate pathway enzymes to ultimately 
produce inhibition of p-aminobenzoic acid 
(PABA) synthesis, and thus folic acid production 
[33, 34]. Mutants defective in the pre-chorismate 
pathway have vaccine potential. Aromatic-
dependent mutants of the pathogenic bacteria 
Salmonella spp. which shares similarity to M. 
tuberculosis in being intracellular pathogen [35, 
36], Bordetella pertusis [37], Yersinia enterocolitica 
[38], Bacillus anthracis [39] and Aeromonas 
salmonicida [40] have been shown to be avirulent 
and stimulate protective immunity. Para amino-
salicylic acid is one of the drugs used in the 
treatment of tuberculosis; the drug mode of 
action is on this pathway by mimicking the 
compound p-aminobenzoic acid and thereby 
leads into wrongful incorporation of this agent 
in the folate synthesis thereby thwarting 
nucleotide synthesis. This drug is also known to 
have some inhibitory effect at some stage in iron 
metabolism [41]. This study confirms the 
importance of pre-chorismate pathway to the 
survival of M. tuberculosis during intracellular 
infection of macrophages. Before meaningful 
intervention can take place, there is need for 
detail knowledge of the enzymes of this 
pathway. Searching the mycobacterial DNA 
database, it appears that there is only one copy 
of aroF gene, as it is in Streptomyces coelicolor [42] 
which in contrast to Staphylococcus aureus which 
has more than one copy. This indicates that the 
disruption of this gene  could be lethal to the 
organism since there is no gene to complement 
the function of this gene. Also, means the 
control of the aroF gene may be complicated in 
this organism since the product of the 
compounds it catalyses is a precursor of many 
metabolites including secondary metabolites. 
The other genes of pre-chorismic pathway are in 
clusters with the exception of aroE gene that 
codes for shikimate-5-dehydrogenase on the 
cosmid MTCY159 on the Sanger’s sequencing 
database. In this study, we show that aroF gene 
expression is upregulated in M. tuberculosis 
during macrophage infection. In addition we 
provide plausible reasons for the importance of 
this pathway to the survival of M. tuberculosis 
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and demonstrate the value of the RAP-PCR in 
detecting some of the genes that might play 
important or additional roles during 
intracellular infection. Work is under progress in 
characterising the condition inside the 
phagocytes which could be multifactorial, in 
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